Mayo Foundation | GenomeWeb

Mayo Foundation

NEW YORK (GenomeWeb News) — Roche Molecular Systems has sued Cepheid for allegedly infringing a US patent assigned to Roche and covering PCR-based methods for detecting Mycobacterium tuberculosis and drug resistance, according to court documents filed this week.

NEW YORK (GenomeWeb News) – Mayo Clinic in Florida said today that it has received a $5 million private donation to help fund the launch and operations of a new clinical center in Jacksonville that will use genomic technologies to tailor treatments to individual patients.

GE Healthcare has been awarded US Patent No. 8,507,662, "Methods and kits for reducing non-specific nucleic acid amplification."
John Nelson, Robert Duthie, Sonali Shah, and Clifford Smith are named as inventors.

NEW YORK (GenomeWeb News) – Newly minted public company Cancer Genetics has disclosed that it will invest at least $2.0 million, and potentially up to $6.0 million, into a joint venture the firm formed in November 2011 with the Mayo Foundation for Medical Education and Research.

The Mayo Foundation for Medical Education and Research has been awarded US Patent No. 8,362,227, "Detection of Clostridium difficile."
Franklin Cockerill, Thomas Smith, Jon Rosenblatt, and Lynne Sloan are named as inventors.

BioRegion Newsmakers

Premium

Sonny Perdue, Elias Zerhouni, Rick Jory, Jack Wheeler, Richard Duke, Joe Bagan Chris Clement, Dick Hinson, Jim Kasic, Carin Kutcipal, Mark Lupa, Frank Ronchetti, John Foster, Marco Baccanti

The state legislature is considering granting $16 million over two years for Mayo and the University of Minnesota joint medical genomics and biotech studies.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.